<DOC>
	<DOC>NCT02594046</DOC>
	<brief_summary>This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks.</brief_summary>
	<brief_title>The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia</brief_title>
	<detailed_description>This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks. Hair count and thickness will be primary outcomes.</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<criteria>androgenic alopecia basic and specific(BASP) classification: M2, C2, U1, V1, or F1 or higher patient of scalp disease</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>